tiprankstipranks
Trending News
More News >
BPL Limited (IN:BPL)
:BPL
India Market
Advertisement

BPL Limited (BPL) AI Stock Analysis

Compare
0 Followers

Top Page

IN:BPL

BPL Limited

(BPL)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 4o)
Rating:50Neutral
Price Target:
₹61.00
▲(1.99% Upside)
The overall stock score is primarily influenced by financial stability and low leverage, but significant challenges in profitability and operational efficiency weigh heavily. Technical indicators suggest bearish momentum, and the negative P/E ratio highlights valuation concerns.
Positive Factors
Strong Balance Sheet
A strong balance sheet with low leverage provides BPL Limited with financial stability and flexibility to invest in growth opportunities.
Revenue Growth
Consistent revenue growth indicates a positive trajectory, suggesting BPL's products and services are gaining market traction.
Cash Flow Improvement
Improved cash flow generation enhances BPL's ability to fund operations, reduce debt, and invest in strategic initiatives.
Negative Factors
Profit Margin Decline
Declining profit margins indicate challenges in cost management and pricing power, potentially impacting long-term profitability.
Operational Inefficiencies
Operational inefficiencies can hinder BPL's ability to scale effectively, affecting its competitive position and profitability.
Low Return on Equity
Low return on equity suggests that BPL is not effectively utilizing its equity base to generate profits, which may deter investors.

BPL Limited (BPL) vs. iShares MSCI India ETF (INDA)

BPL Limited Business Overview & Revenue Model

Company DescriptionBPL Limited (BPL) is a prominent player in the healthcare and consumer electronics sectors, primarily based in India. The company specializes in manufacturing and distributing a wide range of medical devices, healthcare solutions, and electronic products. BPL's core offerings include diagnostic equipment, imaging systems, patient monitoring solutions, and consumer appliances, catering to both healthcare institutions and individual consumers. With a strong focus on innovation and quality, BPL aims to enhance healthcare accessibility and improve patient outcomes across the region.
How the Company Makes MoneyBPL Limited generates revenue through multiple streams, primarily by selling medical devices and healthcare solutions to hospitals, clinics, and healthcare providers. The company has established key partnerships with various healthcare institutions and government agencies, which facilitate large-scale procurement of its products. Additionally, BPL earns income from consumer electronics sales, including home appliances. The company also benefits from service contracts related to maintenance and support of its medical equipment, providing a steady revenue flow. Furthermore, strategic collaborations with international firms for technology exchange and product development enhance its market reach and revenue potential.

BPL Limited Financial Statement Overview

Summary
Income Statement
65
Positive
Balance Sheet
75
Positive
Cash Flow
70
Positive
BreakdownTTMDec 2025Dec 2025Dec 2024Dec 2023Dec 2022
Income Statement
Total Revenue784.49M783.59M664.25M522.16M382.07M
Gross Profit353.72M260.54M336.90M215.40M115.52M
EBITDA-58.34M46.17M194.52M155.31M107.85M
Net Income-105.50M942.00K132.91M50.91M129.50M
Balance Sheet
Total Assets6.18B6.13B6.16B5.99B5.36B
Cash, Cash Equivalents and Short-Term Investments19.76M15.24M97.70M15.91M6.43M
Total Debt312.07M101.12M300.93M228.55M138.27M
Total Liabilities2.32B2.29B2.32B2.28B2.35B
Stockholders Equity2.52B2.49B2.49B2.36B1.66B
Cash Flow
Free Cash Flow-7.67M152.95M-19.57M18.40M-8.90M
Operating Cash Flow-6.71M159.34M42.92M62.59M-6.61M
Investing Cash Flow942.00K515.25M-77.97M42.88M36.28M
Financing Cash Flow10.19M-2.94M61.56M-101.67M-38.76M

BPL Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price59.81
Price Trends
50DMA
71.75
Negative
100DMA
77.06
Negative
200DMA
78.85
Negative
Market Momentum
MACD
-3.50
Negative
RSI
25.31
Positive
STOCH
28.45
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BPL, the sentiment is Negative. The current price of 59.81 is below the 20-day moving average (MA) of 64.71, below the 50-day MA of 71.75, and below the 200-day MA of 78.85, indicating a bearish trend. The MACD of -3.50 indicates Negative momentum. The RSI at 25.31 is Positive, neither overbought nor oversold. The STOCH value of 28.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BPL.

BPL Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
₹113.46B57.290.24%40.14%53.51%
66
Neutral
₹10.86B13.821.15%8.27%195.27%
65
Neutral
$15.17B7.614.09%5.20%3.87%-62.32%
61
Neutral
₹833.86B56.590.06%75.56%103.31%
57
Neutral
₹10.59B31.320.46%39.01%-42.51%
57
Neutral
₹5.74B28.170.24%64.71%48.65%
50
Neutral
₹3.00B9.12%-177.06%
* Energy Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:BPL
BPL Limited
59.81
-62.64
-51.16%
IN:DIXON
Dixon Technologies (India) Ltd.
13,751.25
-3,575.84
-20.64%
IN:SWELECTES
Swelect Energy Systems Limited
658.20
-418.64
-38.88%
IN:TDPOWERSYS
TD Power Systems Limited
697.70
248.45
55.30%
IN:TNPETRO
Tamilnadu Petro Products Ltd.
104.90
21.17
25.28%
IN:ZODIAC
Zodiac Energy Ltd.
316.50
-225.18
-41.57%

BPL Limited Corporate Events

BPL Limited Announces Strategic Operational Update
Sep 7, 2025

BPL Limited has announced a significant update in its operations, which is expected to have a notable impact on its market positioning. The company has made strategic moves to enhance its operational efficiency and market reach, which could lead to improved stakeholder value and competitive advantage.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 26, 2025